Global Oncology Based Molecular Diagnostics Market Size & Outlook
The oncology based molecular diagnostics industry worldwide is expected to reach a projected revenue of US$ 6,004.5 million by 2030. A compound annual growth rate of 12.1% is expected of the worldwide oncology based molecular diagnostics industry from 2024 to 2030.
Revenue, 2023 (US$M)
$2,701.0
Forecast, 2030 (US$M)
$6,004.5
CAGR, 2024 - 2030
12.1%
Report Coverage
Worldwide
Global oncology based molecular diagnostics market, 2018-2030 (US$M)
Related Markets
Global oncology based molecular diagnostics market highlights
- The global oncology based molecular diagnostics market generated a revenue of USD 2,701.0 million in 2023 and is expected to reach USD 6,004.5 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 12.1% by 2030.
- In terms of segment, instruments accounted for a revenue of USD 2,701.0 million in 2023.
- Instruments is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
Global data book summary
| Market revenue in 2023 | USD 2,701.0 million |
| Market revenue in 2030 | USD 6,004.5 million |
| Growth rate | 12.1% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Instruments |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments |
Other key industry trends
- In terms of revenue, the North America accounted for 43.9% of the global oncology based molecular diagnostics market in 2023.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oncology based Molecular Diagnostics Market Scope
Oncology based molecular diagnostics market segmentation & scope
Technology
PCR
In Situ Hybridization
INAAT
Chips and microarrays
Mass spectrometry
Sequencing
TMA
Others
U.S.
Canada
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Mexico
Brazil
South Africa
Saudi Arabia
UK
Argentina
UAE
Kuwait
Oncology based Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global oncology based molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology based molecular diagnostics market will help companies and investors design strategic landscapes.
instruments was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Global oncology based molecular diagnostics market based on instruments covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Oncology based Molecular Diagnostics Product Outlook (Revenue, USD Million, 2018-2030)
- Instruments
- Reagents
- Others
- Global Oncology based Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
- PCR
- In Situ Hybridization
- INAAT
- Chips and microarrays
- Mass spectrometry
- Sequencing
- TMA
- Others
Reasons to subscribe to Global oncology based molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global oncology based molecular diagnostics market databook
-
Our clientele includes a mix of oncology based molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global oncology based molecular diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global oncology based molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global oncology based molecular diagnostics market statistics, by regions, 2018-2030 (US$M)
Top 10 countries: Oncology based molecular diagnostics market size, 2023 (USD Million)
Top 10 countries: Oncology based molecular diagnostics market size, 2023 (USD Million)
Global oncology based molecular diagnostics market, by region, 2023 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
